(Q73684895)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

M Ashby

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

B Fleming

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Wood

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Somogyi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 September 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pain and Symptom Management

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

157-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

Individual variability in the response to different opioids: report of five cases

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Changing pattern of agitated impaired mental status in patients with advanced cancer: Association with cognitive monitoring, hydration, and opioid rotation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Opioid rotation for toxicity reduction in terminal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine-6-glucuronide, a potent mu agonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine-6-glucuronide has high affinity for the opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Mu receptor binding of some commonly used opioids and their metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Analgesic Effect of Morphine Glucuronides

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

The analgesic activity of morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Enhanced binding of morphine and nalorphine to opioid delta receptor by glucuronate and sulfate conjugations at the 6-position

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

The spinal antinociceptive actions of morphine metabolites morphine-6-glucuronide and normorphine in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Intrathecal high dose morphine produces hyperalgesia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Opioid hyperexcitability: the application of alternate opioid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine-3-glucuronide--a potent antagonist of morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

1 reference

7 January 2021

Oral morphine in cancer pain: influences on morphine and metabolite concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Chronic nausea and morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

The influence of renal function on the renal clearance of morphine and its glucuronide metabolites in intensive‐care patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

The pharmacokinetics of morphine and morphine glucuronides in kidney failure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studies

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Kinetics of morphine in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Morphine-6-glucuronide disposition in renal impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

Influence of renal function on the elimination of morphine and morphine glucuronides.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2897%2900020-1

7 January 2021

10.1016/S0885-3924(97)00020-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9291702%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference